The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
European Journal of Clinical Pharmacology1994Vol. 46(5), pp. 405–410
Citations Over TimeTop 13% of 1994 papers
Serena Tonstad, D Pometta, D.W. Erkelens, Ose L, Tiziano Moccetti, J. A. Schouten, A. Golay, Johannes B. Reitsma, A. Del Bufalo, Elena Pasotti, P. van der Wal
Related Papers
- Weight loss medications--where do they fit in?(2006)
- → 10.1016/b978-0-7295-3951-7.50048-3(2000)4 cited
- Effects of high levels of DHA and EPA triglyceride on blood lipid and protection of the liver in hyperlipidemia mice(2014)
- → Management of Obesity(2008)1 cited
- → Orlistat and Sibutramine in the Management of Obesity(2007)